NASDAQ

AnaptysBio, Inc. (ANAB)

♥ 590 Thanks from members

Live price chart, market sentiment, and community perspectives for AnaptysBio, Inc. (NASDAQ: ANAB).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: John R. MendleinFounder: Peter DiLauraLeadership: Ketan Patel (CEO)Leadership: Marc Goldstein (CFO)Holder: Baker Bros. AdvisorsHolder: FMR LLCHolder: BlackRock, Inc.ImsidolimabANB032ANB033ROAM Platform#ANAB#AnaptysBio#biotech stock#immunology therapeutics#clinical stage pharma